Vanguard Health Care Fund Buys Royal Philips NV, Seattle Genetics Inc, Portola Pharmaceuticals Inc, Sells Dentsply Sirona Inc, Edwards Lifesciences Corp, Shanghai Fosun Pharmaceutical (Group) Co

• New Purchases: PHIA, SGEN, AVXS,
• Added Positions: PTLA, CVS, ARE, REGN, NOVN, AGIO, AGN, ALNY, HOLX, 4516,
• Reduced Positions: VRTX, MRK, ABT, BMY, LLY, HCA, CERN, UNH, ROG, TEVA,
• Sold Out: XRAY, EW, 02269,

For the details of Vanguard Health Care Fund's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Vanguard+Health+Care+Fund

1. Bristol-Myers Squibb Company (BMY) - 46,688,361 shares, 6.6% of the total portfolio. Shares reduced by 3.8%
2. UnitedHealth Group Inc (UNH) - 11,953,085 shares, 5.72% of the total portfolio. Shares reduced by 2.73%
3. AstraZeneca PLC (AZN) - 35,892,482 shares, 5.52% of the total portfolio.
4. Allergan PLC (AGN) - 13,428,401 shares, 5.05% of the total portfolio. Shares added by 1.60%
5. Eli Lilly and Co (LLY) - 24,989,415 shares, 4.32% of the total portfolio. Shares reduced by 4.76%

Vanguard Health Care Fund initiated holding in Royal Philips NV. The purchase prices were between $29.63 and $33.9, with an estimated average price of $31.91. The stock is now traded at around $35.21. The impact to a portfolio due to this purchase was 0.27%. The holding were 3,110,045 shares as of 2018-03-31.

Vanguard Health Care Fund initiated holding in Seattle Genetics Inc. The purchase prices were between $50.14 and $59.32, with an estimated average price of $54.49. The stock is now traded at around $51.89. The impact to a portfolio due to this purchase was 0.22%. The holding were 1,911,900 shares as of 2018-03-31.

Vanguard Health Care Fund initiated holding in AveXis Inc. The purchase prices were between $102.08 and $136.93, with an estimated average price of $118.65. The stock is now traded at around $216.49. The impact to a portfolio due to this purchase was 0.05%. The holding were 195,461 shares as of 2018-03-31.

Vanguard Health Care Fund added to a holding in Portola Pharmaceuticals Inc by 1625.38%. The purchase prices were between $30.57 and $54.27, with an estimated average price of $43.88. The stock is now traded at around $35.18. The impact to a portfolio due to this purchase was 0.2%. The holding were 2,913,937 shares as of 2018-03-31.

Vanguard Health Care Fund added to a holding in CVS Health Corp by 36.57%. The purchase prices were between $60.6 and $83.63, with an estimated average price of $71.75. The stock is now traded at around $68.46. The impact to a portfolio due to this purchase was 0.17%. The holding were 4,518,118 shares as of 2018-03-31.

Vanguard Health Care Fund added to a holding in Alexandria Real Estate Equities Inc by 112.68%. The purchase prices were between $114.58 and $129.93, with an estimated average price of $124.08. The stock is now traded at around $128.89. The impact to a portfolio due to this purchase was 0.17%. The holding were 1,162,300 shares as of 2018-03-31.

Vanguard Health Care Fund sold out a holding in Dentsply Sirona Inc. The sale prices were between $49.95 and $68.3, with an estimated average price of $58.89.

Vanguard Health Care Fund sold out a holding in Edwards Lifesciences Corp. The sale prices were between $111.58 and $142.34, with an estimated average price of $130.28.

Vanguard Health Care Fund sold out a holding in WuXi Biologics (Cayman) Inc. The sale prices were between $6.9 and $9.77, with an estimated average price of $7.11.